Study of Cryoablation and Nirogacestat for Desmoid Tumor

Trial ID or NCT#

NCT05949099

Status

recruiting iconRECRUITING

Purpose

The primary purpose of this protocol is Systemic therapy with oral study agent, nirogacestat, followed by a single cryoablation procedure.

Official Title

Phase II Study of Cryoablation and Nirogacestat for Desmoid Tumor

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Nam Quoc Bui
Nam Quoc Bui
Medical oncologist, Sarcoma specialist
Clinical Associate Professor, Medicine - Oncology
Minggui Pan, MD, PhD
Minggui Pan, MD, PhD
Medical oncologist, Sarcoma specialist
Clinical Professor, Medicine - Oncology
Pejman Ghanouni, MD, PhD
Pejman Ghanouni, MD, PhD
Radiologist
Professor of Radiology (Body MRI) and, by courtesy, of Neurosurgery, of Obstetrics and Gynecology and of Urology
Kristen N Ganjoo
Kristen N Ganjoo
Sarcoma specialist, Medical oncologist
Professor of Medicine (Oncology)

Contact us to find out if this trial is right for you.

Contact

Behnaz Agahian
650-498-0623

SEND MESSAGE

View on ClinicalTrials.gov